Concepedia

Shaily Arora

SA

Statistics

Publications

9

Citations

674

H-Index

9

Active since

2010

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Center for Devices and Radiological Health

University of Kentucky

Shaily Arora is an author at United States Food and Drug Administration specializing in medicine, acute kidney injury, and cancer therapeutics.

Top concepts

Publications per year

2010–2022

9

Publications

9

FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer

Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang et al. · The Oncologist · 2020 · 171 citations · Full text

FDA Approval Summary: Pembrolizumab plus Lenvatinib for Endometrial Carcinoma, a Collaborative International Review under Project Orbis

Shaily Arora, Sanjeeve Balasubramaniam, Wei Zhang et al. · Clinical Cancer Research · 2020 · 99 citations · Full text

The C. elegans Rab Family: Identification, Classification and Toolkit Construction

Maria Gallegos, Sanjeev Balakrishnan, Priya Chandramouli et al. · PLoS ONE · 2012 · 94 citations · Full text

, , +20

Use of Single-Arm Trials for US Food and Drug Administration Drug Approval in Oncology, 2002-2021

Sundeep Agrawal, Shaily Arora, Laleh Amiri‐Kordestani et al. · JAMA Oncology · 2022 · 73 citations

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i>-Mutated Metastatic Castrate-Resistant Prostate Cancer

Mitchell S. Anscher, Elaine Chang, Xin Gao et al. · The Oncologist · 2020 · 68 citations · Full text

, , +14

1–5 of 9